Radial nerve lesion

Summary

Radial nerve lesion (MONDO:0006940) is a disease. A subtype of radial neuropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	radial nerve lesion
Mondo ID	MONDO:0006940
EFO	EFO:1001143
DOID	DOID:12170
ICD-10-CM	G56.3
SNOMED CT	193137006
UMLS	C0154744
MedGen	102317
GARD	0024504
MedDRA	10061477
Anatomy (UBERON)	UBERON:0001492
Is cancer (heuristic)	no

Also known as: lesion of radial nerve · peripheral nerve lesion of radial nerve · radial nerve peripheral nerve lesion

Disease family

This is a subtype of radial neuropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral neuropathy › mononeuropathy › radial neuropathy › radial nerve lesion

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.